New hope for blood cancer patients
The TGA has approved a new therapy for patients with myeloma.
The blood cancer claims around 900 Australian lives a year- a statistic that’s increase by 14 per cent in the last decade.
Darzalex activates the immune system to identify and kill cancer cells where other medicines have had less success.
Chris spoke to Professor Miles Prince to find out more.
Download this podcast here